Keywords: Juvenile; Isoflavone; Preclinical Toxicity; Diet; Mineralization; Basophilic tubules; BUN; Blood Urea Nitrogen; CPN; Chronic Progressive Nephropathy; Cr; Creatinine; DART; Developmental And Reproductive Toxicity; EOGRT; Extended One-Generation Reproductiv
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: FTIH; first time in human; PP-HOP; pleural pressure-head out plethysmography; WBP; whole body plethysmography; i.t.; intra tracheal; VT; tidal volume; Bpm; breaths per minute; MV; minute volume; ICH; The International Council for Harmonisation of Technica
Keywords: CCK; cholecystokinin; CNS; central nervous system; EEC; enteroendocrine cell; FFAR; free fatty acid receptor; GABA; gamma-aminobutyric acid; GI; gastrointestinal; GLP; glucagon-like peptide; IB4; isolectin B4; IBD; inflammatory bowel disease; LPS; lipopol
Keywords: CIGAA; consortium for the investigation of genotoxicity of aromatic amines; GLP; good laboratory practice; KNIME; the Konstanz Information Miner; pAAs; primary aromatic amines; (Q)SAR; quantitative structure-activity relationship; SMARTS; SMiles ARbitrary
Keywords: Safety; Preclinical; Rodent; Salicylamine; γ-Ketoaldehydes; 2-HOBA; 2-hydroxybenzylamine; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BUN; blood urea nitrogen; BW; body weight; FDA; Food and Drug Administration; GLP; good laboratory p
Keywords: ACAT; acyl-coenzyme A:cholesterol acyltransferases; BSH; bile salt hydrolase; CFU; colony-forming unit; FAS; fatty acid synthase; FXR; farnesoid X receptor; GA; gum Arabic; GLP; glucagon-like peptides; HDL-C; high density lipoproteins cholesterol; HFD; hi
Keywords: MTBE; methyl tert-butyl ether; MF; matrix factor; Dexamphetamine; HPLC-MS/MS; Plasma; Validation; GLP;
Keywords: CV; coefficient of variation; CS; calibration standard; DMSO; dimethylsulfoxide; EMA; European Medicine Agency; FDA; Food and Drug Administration; GCP; Good Clinical Practice; GLP; Good Laboratory Practice; IS; internal standard; K3EDTA; tripotassium ethy
Keywords: Mulberry leaf extract; Rat; Subacute toxicity; Genotoxicity; Ames assay; Micronucleus; Sperm abnormality; Safety assessment; 1,8-DHAQ; 1,8-dihydroxyanthraquinone; 2-AF; 2-aminofluorene; 4-NO; 4-nitro-O-phenylenediamine; ALB; albumin; ALP; alkalinephosphat
Keywords: Quality; Transitivity; Traceability; Quality marker; Herbal medicinal product; AHP; The American Herbal Pharmacopoeia; BA; biopotency assay; BHP; The British Herbal Pharmacopoeia; CHM; Chinese herbal medicines; CMC; chemistry manufacturing controls; CMM;
Keywords: ROS; reactive oxygen species; SOD; superoxide dismutase; ATP; adenosine triphosphate; PEG; polyethylene glycol; MDA; malondialdehyde; PS II; photosystem II; Fo; initial fluorescence; Fv; variable fluorescence; Fm; maximum fluorescence; SDS; sodium dodecyl
Keywords: DM; dry matter; CP; crude protein; NDF; neutral detergent fibre; ADF; acid detergent fibre; CF; crude fibre; GE; gross energy; EE; ether extract; NE; net energy; OM; organic matter; N; nitrogen; DE; digestible energy; AOAC; Association of Official Agricul
Keywords: Genotoxicity; Isoquercitrin; Enzymatically-modified isoquercitrin; Flavonol; DNA damage; Food additive; AGIQ; alpha-glycosyl isoquercitrin; CGTase; cyclodextrin glucanotransferase; DMSO; dimethyl sulfoxide; EDTA; ethylenediaminetetraacetic acid; EFSA; Eur
Keywords: ADA2; Adenosine deaminase 2; ASH1L; Absent, Small, or Homeotic 1-like; BAF; BRG1 associated factor; BAH; Bromoadjacent homology; BAZ2A; Bromodomain adjacent to zinc finger domain protein 2A; BET; Bromodomain and Extra-Terminal domain; BRPF1; Bromodomain a
Keywords: CMR; cardiovascular magnetic resonance; DLCO; diffusing capacity of the lung for carbon monoxide; GDF-16; growth differential factor 15; GLP; global longitudinal peak systolic strain; LGE; late gadolinium enhancement; PIIINP; procolagen III N Terminal Pro
Keywords: Hydrogen peroxide; Photolysis; Hydroxyl radicals; Periodontal therapy; Oral mucosa irritation; Hamster; GLP; good laboratory practice; ISO; International Organization for Standardization;
Keywords: AUCs; areas-under-the-curve; BMI; body mass index; FFA; fatty free acids; GIP; gastrointestinal glucose-dependent insulinotropic polypeptide; GLP; glucagon-like peptide-1; Bread; Einkorn; Ghrelin; Glycemic areas-under-the-curve; Insulin; Sourdough;
Keywords: Hollow micro-needle; Resistance pressure; Drug delivery; eb; evans blue; Di; deionization; Km; kunming; Asp; ammonium persulfate; Temed; n,n,n',n'-tetramethylethylenediamine; SDS-PAGE; Sodium dodecyl sulfate polyacrylamide gel electrophoresis; GLP; Good l
Bioanalytical method development and validation: Critical concepts and strategies
Keywords: Bioanalysis; Bioanalytical method development; Sample preparation; Liquid chromatography; Tandem mass spectrometry; Method validation; GLP;
Keywords: ventricular assist device (VAD); continuous-flow device; pediatrics; mechanical circulatory support (MCS); pediatrics heart transplantation; ACT; activated clotting time; FDA; Food and Drug Administration; GLP; good laboratory practice; IDE; Investigation
Keywords: AT; ataxia telangiectasia; DSP; dexamethasone sodium phosphate; EDS; EryDex system; EDS-EP; EDS end product; GLP; good laboratory practice; GMP; good manufacturing practice; HCT; hematocrit; HD; healthy donor; HGB; hemoglobin; HPLC; high-performance liqui
Keywords: BDS; bulk drug substance; BPL; β-propiolactone; cGMP; current good manufacturing practices; DENV; dengue virus; DP; drug product; Env; envelope protein; FFA; focus forming assay; GLP; good laboratory practices; H2O2; hydrogen peroxide; IVRP; in vitro rel
Keywords: blood glucose; cardiovascular disease; heart failure; hypoglycemic agents; outcomes; CI; confidence interval; CV; cardiovascular; CVOT; cardiovascular outcomes trial; GLP; glucagon-like peptide; HbA1c; glycosylated hemoglobin; HR; hazard ratio; MACE; majo
Keywords: glucagon-like peptide 2; intestinal failure; pediatric short bowel syndrome; short gut syndrome; AE; Adverse event; EN; Enteral nutrition; GI; Gastrointestinal; GLP; Glucagon-like peptide; IF; Intestinal failure; ITT; Intent-to-treat; PD; Pharmacodynamics
Keywords: Graphene-based nanomaterials; Graphene; Graphene oxide; Reduced graphene oxide; Graphene quantum dots; Toxicity; Inflammation; Biodistribution; In vivo; Ach; acetylcholine; ADD; aerodynamic diameter; AgD; agglomerate density; AgS; Agglomerate size; ApD;
Keywords: Thiophene; Flavoring ingredients; FEMA GRAS; bw; body weight; CYP; cytochrome P450; DNA; deoxyribonucleic acid; DT; decision tree; F; female; FEMA; the Flavor and Extract Manufacturers Association; GLP; good laboratory practice; GRAS; generally recognized
Keywords: TB; tuberculosis; MTB; Mycobacterium tuberculosis; MDR-TB; multi-drug resistant tuberculosis; XDR-TB; extensively drug resistant tuberculosis; TDR-TB; totally drug resistant tuberculosis; INH; isoniazid; WHO; World Health Organization; RIF; rifampicin; PZ
Recent advancements in the development of anti-tuberculosis drugs
Keywords: ADRs; adverse drug reactions; AG; arabinogalactan; AhpE; alkylhydroperoxide reductase E; Alr; d-alanine racemase; AMP; adenosine monophosphate; AnPRT; anthranilate phosphoribosyltransferase; ATP; adenosine triphosphate; BTZ; benzothiazinone; CADD; compute
Keywords: ACC; American College of Cardiology; acLDL; acetylated-low density lipoprotein; AHA; American Heart Association; ALL; acute lymphoblastic leukemia; ANG1; angiopoietin 1; ATMP; Advanced Therapy Medicinal Product; BM; bone marrow; BMSC; bone marrow-derived
Keywords: Honokiol microemulsion; Cerebral ischemia protection; Embryo-fetal development toxicity; AAALAC; Association for Assessment and Accreditation of Laboratory Animal Care; GD; gestation day; GLP; Good Laboratory Practice; ICH; International Conference on Har
Keywords: cardiovascular disease; obesity; pharmacology; prevention; risk factors; BMI; body mass index; FDA; Food and Drug Administration; GLP; glucagon-like peptide; HbA1c; glycosylated hemoglobin; HDL-C; high-density lipoprotein cholesterol; HR; hazard ratio; h
Keywords: Dysbiosis; Diabetes; Metagenomics; Translocation; Intestinal Permeability; ALD; alcoholic liver disease; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CDR; cirrhosis dysbiosis ratio; DHA; docosahexaenoic acid; FXR; farnesoid X receptor;
Keywords: MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; Ara; arabinose; APS; Astragalus membranaceus; DC; dendritic cells; DMEM; dulbeccoâ¿¿s modified eagle medium; FBS; fetal bovine serum; FITC; fluorescein isothiocyanate; GLP; Ganoderma luci
Keywords: ADMA, Asymmetric dimethylarginine; BW, Body weight; BDNF, Brain-derived neurotrophic factor; Br Fat, Brown adipose tissue; CBV, Cerebral blood volume; C-X-C motif, Chemokine; Cxcl1, Ligand 1; CH, Cholesterol; DG, Diacylglycerol; FFA, Free fatty acids; GLP
Keywords: SUD; Substance Use Disorder; SUDs; Substance Use Disorders; CCK; cholecystokinin; NTS; nucleus tractus solitarius; GABA; gamma amino butyric acid; NE; norepinephrine; CeA; central nucleus of the amygdala; EC; enterochromaffin; EE; enteroendocrine; IPAN; i
Keywords: GT; gintonin; LPA; lysophosphatidic acid; [Ca2+]i; intracellular calcium concentration; GLP; ginseng major latex-like protein; Ginseng; Gintonin; Catecholamines; Blood glucose; Rotarod performance;
Keywords: GT; gintonin; LPA; lysophosphatidic acid; [Ca2+]i; intracellular calcium concentration; ATP; adenosine triphosphate; GLP; ginseng major latex-like protein; FBS; fetal bovine serum; HEPES; N-2-hydroxyethyl-piperazine-Nâ²-2-ethanesulfonic acid; Ginseng; Gi
Keywords: Gut microbiota; Diabetes; Metabolism; Inflammation; Fecal transplant; Acc; acetyl-CoA carboxylase; AMPK; adenosine 5â²-monophosphate (AMP)-activated protein kinase; GF; germ-free; GLP; glucagon-like peptide; GPR; G-protein coupled receptor; HbA1c; hemo
Keywords: Ghrelin; GLP; Gut health; Leptin; Stress; Sus scrofa;
Keywords: GLP; good laboratory practice; M:E ratio; myeloid:erythroid ratio; NOS; no otherwise specified; Background findings; Bone marrow; Mice; Rats; Rodents;
Keywords: Aspartame; Genotoxicity in vitro; Genotoxicity in vivo; CA; chromosomal aberrations; CBPI; cytokinesis-block proliferation index; EFSA; European Food Safety Authority; GLP; Good Laboratory Practice; ICH; International Conference on Harmonization of Tech
Keywords: VPP; vortex phase plate; GLP; Glan-laser polarizer; DM; dichroic mirror; MDM; master dichroic mirror; PM; polarization maintaining; MM; multimode; PPI; protein-proximity index; FWHM; full-width-half-maximum; PSF; point spread function; Fluorescence micros
Keywords: 2-AA; 2-aminoanthracene; 2-NF; 2-nitrofluorene; 9-AA; 9-aminoacridine; ARA; arachidonic acid; bw; body weight; CBPI; cytokinesis-blocked proliferation index; DHA; docosahexaenoic acid; DMSO; dimethyl sulfoxide; F1; first generation; FOB; functional observ
Keywords: α-GST; alpha-glutathione S-transferase; B2M; beta-2 microglobulin; BUN; blood urea nitrogen; CROs; contract research organisations; Cr; creatinine; CysC; cystatin C; DIKI; drug-induced kidney-injury; EFPIA; European Federation of Pharmaceutical Industrie
Keywords: DPI; diphenylene iodonium chloride; CuAO; copper-containing amine oxidase; GLP; germin-like protein; KCN; potassium cyanide; MAMP; microbe-associated molecular pattern; Nox; NADPH oxidase; PAMP; pathogen-associated molecular pattern; PAO; polyamine oxidas
Keywords: advanced therapy medicinal product; advanced therapy medicinal product with hospital exemption; genetically modified organism; market access; ADI; aid for development of innovation; AFM; French Association against Myopathies (Association Française contre
Keywords: Genotoxicity; Cobalt compounds; Overall assessment; 2-AA; 2-aminoanthracene; 2NF; 2-nitrofluorene; 4-NOPD; nitro-o-phenylenediamine; 6Â TG; 6-thioguanine; 8-OH-dG; 8-hydroxy-2-deoxyguanosine; 9AA; 9-aminoacridine; AAF; artificial alveolar fluid; B[a]P; be
Keywords: Satiation; Satiety; Stomach; Neurohormonal; AA; amino acids; ARC; arcuate nucleus; BMI; body mass index; CCK; cholecystokinin; FFAR; free fatty acid receptor; GIP; glucose-dependent insulinotropic peptide; GLP; glucagon-like peptide; GPR120; G protein cou
Keywords: 5-FU; 5-fluorouracil; API; active pharmaceutical ingredient; ADA; anti-drug antibodies; CSE; control standard endotoxin; CTL; cytotoxic T lymphocytes; CARPA; complement activation-related pseudoallergy; CHAPS; 3-[(3-Cholamidopropyl)dimethylammonio]-1-;
Keywords: bariatric; loss; psoriasis; surgery; treatment; weight; AGB; adjustable gastric banding; EWL; excess weight loss; GLP; glucagon-like peptide; RYGB; Roux-en-Y gastric bypass; TNF; tumor necrosis factor;